abstract |
The present invention provides a novel targeted heterodimeric Fc fusion protein comprising an IL-15 / IL-15Ra Fc fusion protein and a Fc antigen binding domain of fusion proteins. In some cases, the antigen binding domain binds to CD8, NKG2A, or NKG2D. |